Edition:
United Kingdom

People: AMAG Pharmaceuticals Inc (AMAG.OQ)

AMAG.OQ on NASDAQ Stock Exchange Global Select Market

11.40USD
16 Aug 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$11.40
Open
$11.51
Day's High
$11.64
Day's Low
$11.27
Volume
413,556
Avg. Vol
326,526
52-wk High
$25.15
52-wk Low
$6.81

Vittiglio, Joseph 

Mr. Joseph D. Vittiglio is Executive Vice President, General Counsel and Corporate Secretary of the Company. Prior to joining us, Mr. Vittiglio served from March 2015 to August 2015 as Vice President of Legal Affairs and a member of the Management Committee at Flexion Therapeutics, Inc. (“Flexion”), a public pharmaceutical company. Prior to Flexion, Mr. Vittiglio was the General Counsel and Secretary of AVEO Pharmaceuticals, Inc., a public biopharmaceutical company, from 2007 to March 2015. From 2005 to 2007, he served as Director of Corporate Legal Affairs at Oscient Pharmaceuticals Corporation (“Oscient”), a public pharmaceutical company. Prior to Oscient, Mr. Vittiglio was a senior corporate associate from 1998 to 2005 at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC. Mr. Vittiglio holds a B.A. in International Relations from Tufts University and a J.D. from Northeastern University School of Law.

Basic Compensation

Total Annual Compensation, USD 569,070
Restricted Stock Award, USD 402,150
Long-Term Incentive Plans, USD --
All Other, USD 232,492
Fiscal Year Total, USD 1,203,710

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gino Santini

282,981

William Heiden

4,966,220

Edward Myles

1,537,340

Elizabeth Bolgiano

--

Joseph Vittiglio

1,203,710

J. Alan Butcher

2,083,060
As Of  31 Dec 2018